Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AMAG Pharmaceuticals Inc (NASDAQ:AMAG)

17.45
Delayed Data
As of 4:00pm ET
 +0.85 / +5.12%
Today’s Change
16.00
Today|||52-Week Range
36.83
-49.86%
Year-to-Date
No recent news for AMAG Pharmaceuticals Inc.

Today’s Trading

Previous close16.60
Today’s open16.70
Day’s range16.70 - 17.60
Volume836,021
Average volume (3 months)1,070,256
Market cap$585.8M
Dividend yield--
Data as of 4:00pm ET, 08/16/2017

Growth & Valuation

Earnings growth (last year)-107.53%
Earnings growth (this year)-16.17%
Earnings growth (next 5 years)+4.40%
Revenue growth (last year)+27.21%
P/E ratioNM
Price/Sales2.25
Price/Book0.61

Competitors

 Today’s
change
Today’s
% change
SYRSSyros Pharmaceutical...-1.40-6.27%
NTLAIntellia Therapeutic...-0.06-0.36%
CHRSCoherus BioSciences ...-0.25-2.13%
IMGNImmunoGen Inc-0.16-2.55%
Data as of 4:00pm ET, 08/16/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$1.25
Annual revenue (last year)$532.1M
Annual profit (last year)-$2.5M
Net profit margin-0.47%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
William K. Heiden
Chief Financial Officer, Treasurer &
Senior VP
Edward H. Myles
Corporate headquarters
Waltham, Massachusetts

Forecasts